May 24, 2021 7:00 am EDT Castle Biosciences to Host Ribbon Cutting Ceremony at New Corporate Headquarters
May 21, 2021 7:00 am EDT Castle Biosciences Supports the American Skin Association with Research Grant
May 20, 2021 7:00 am EDT Expert Panel Provides Framework for Incorporating DecisionDx-SCC Results Into Clinical Decision Making for Cutaneous Squamous Cell Carcinoma Patients With One or More Risk Factors
May 19, 2021 7:00 am EDT Castle Biosciences to Participate in the Oppenheimer MedTech, Tools, & Diagnostics Summit
May 11, 2021 7:00 am EDT Tiffany Olson, Seasoned Diagnostics Executive, Joins Castle Biosciences’ Board of Directors
May 10, 2021 4:05 pm EDT Castle Biosciences Announces Pipeline Initiative to Develop Genomic Test Targeting Systemic Therapy Response in Patients with Psoriasis, Atopic Dermatitis and Related Conditions
May 6, 2021 8:00 am EDT Castle Biosciences Recognized for Skin Cancer Diagnostics Innovation in 2021 MedTech Breakthrough Awards Program
